MBD2 and neoplasm: PyMT upregulates Mbd2, and upregulation of Mbd2 precedes the appearance of measurable primary tumors, consistent with the idea that Mbd2 partially mediates the effects of PyMT on cellular pathways that drive tumor progression; specifically, Mbd2 deletion inhibits the activation of these pathways.